Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, May 13, 2022
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
Thu, May 12, 2022
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
Nathan Rich Maintained (AMRX) at Strong Buy with Decreased Target to $4.5 on, May 12th, 2022
Nathan Rich of Goldman Sachs, Maintained "Amneal Pharmaceuticals, Inc." (AMRX) at Strong Buy with Decreased Target from $6 to $4.5 on, May 12th, 2022.
Nathan, nor any peers, have made any analyst calls on AMRX in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30